First JAK Inhibitor Approved for Crohn's Disease

(MedPage Today) -- The FDA approved upadacitinib (Rinvoq) for treating Crohn's disease, representing the first Janus kinase (JAK) inhibitor for the condition, the agency announced on Thursday. Specifically, the once-daily pill is indicated for...
Source: MedPage Today Public Health - Category: American Health Source Type: news